Noncoding RNA-mediated regulation of pyroptotic cell death in cancer

Man Wang1, Yuan Zhang1, Wenguang Chang1

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China.

Frontiers in Oncology
|November 17, 2022
PubMed

Insights

Pyroptosis, a programmed cell death, is linked to cancer. Noncoding RNAs (ncRNAs) regulate pyroptosis, influencing cancer development and offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Mechanisms

Background:

  • Pyroptosis is a programmed cell death form associated with cancer initiation and progression.
  • Molecular mechanisms linking pyroptosis and cancer remain largely unclear.
  • Noncoding RNAs (ncRNAs) are critical gene regulators in physiological and pathological processes, including cancer.

Purpose of the Study:

  • To review the multifaceted roles of ncRNAs in pyroptosis.
  • To elucidate the mechanisms of the ncRNA-pyroptosis axis in cancer pathogenesis.
  • To discuss the therapeutic potential of pyroptosis-regulating ncRNAs in oncology.

Main Methods:

  • Literature review focusing on ncRNAs (miRNAs, lncRNAs, circRNAs) and pyroptosis.
  • Analysis of molecular mechanisms underlying the ncRNA-pyroptosis interaction in cancer.
  • Discussion of current research trends and future directions.

Main Results:

  • NcRNAs, including miRNAs, lncRNAs, and circRNAs, significantly modulate pyroptosis.
  • The interplay between ncRNAs and pyroptosis impacts cancer hallmarks like growth, survival, metastasis, and therapeutic resistance.
  • Emerging evidence highlights the ncRNA-pyroptosis axis as a key player in cancer pathobiology.

Conclusions:

  • NcRNAs are crucial regulators of pyroptosis, impacting cancer development.
  • Targeting the ncRNA-pyroptosis axis presents promising avenues for cancer diagnostics and therapeutics.
  • Further research is needed to fully exploit pyroptosis-regulating ncRNAs in clinical settings.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K